Does desvenlafaxine get excreted unchanged in the feces?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Desvenlafaxine Excretion in Feces

No, desvenlafaxine does not come out whole in feces. Approximately 45% of desvenlafaxine is excreted unchanged in urine, while less than 5% appears in feces, primarily as metabolites rather than intact drug 1.

Pharmacokinetic Profile

Desvenlafaxine undergoes the following elimination pathways:

  • Urinary excretion (primary route): ~45% excreted unchanged in urine at 72 hours post-administration
  • Glucuronide metabolite: ~19% excreted in urine as the conjugated form
  • Oxidative metabolite: <5% excreted as N,O-didesmethylvenlafaxine in urine
  • Fecal excretion (minor route): Minimal amounts, primarily as metabolites 1

Metabolism and Elimination

Desvenlafaxine is primarily metabolized by conjugation (mediated by UGT isoforms) rather than through extensive hepatic oxidation 1. The drug has:

  • Oral bioavailability: Approximately 80%
  • Half-life: ~10 hours 2
  • Protein binding: Only 30% (relatively low) 1
  • Volume of distribution: 3.4 L/kg 1

Key Metabolic Characteristics

The CYP2D6 pathway is not involved in desvenlafaxine metabolism, and CYP3A4 plays only a minor role in N-demethylation 1. This results in:

  • Minimal drug-drug interactions compared to other antidepressants 3, 2
  • Predictable pharmacokinetics across different CYP2D6 metabolizer phenotypes 1
  • No significant differences between poor and extensive CYP2D6 metabolizers 1

Clinical Implications

You will not see intact desvenlafaxine tablets in stool under normal circumstances. However, patients may notice an inert matrix tablet passing in stool or via colostomy, which is the inactive delivery system after the active medication has already been absorbed 1.

Dosing Considerations Based on Elimination

Since renal excretion is the primary elimination pathway, dosage adjustments are necessary in renal impairment but generally not required for hepatic dysfunction (unless severe) 1. The drug's minimal fecal excretion means gastrointestinal issues are unlikely to significantly affect drug elimination.

References

Research

Desvenlafaxine succinate for major depressive disorder.

Drugs of today (Barcelona, Spain : 1998), 2008

Research

Desvenlafaxine in the treatment of major depressive disorder.

Neuropsychiatric disease and treatment, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.